Article
Optimal Use of CDK4/6 Inhibitors in Breast Cancer
- Author:
- Virginia Kaklamani, MD; Harold J. Burstein, MD, PhD
Publish date: March 29, 2023
Leading oncologists discuss the role of CDK4/6 inhibitors in all stages of HR+/HER2- breast cancer, including robust results on the use of...